Chemomab Therapeutics Ltd.
SEC CIK 1534248 · CMMB · last insider filing 2026-06-03
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Melincoff Gwen A | Director | filed 2026 - 2026 |
| Mor George Adi | Director · Chief Scientific Officer | filed 2021 - 2026 |
| Darvish Nissim | Director | filed 2021 - 2026 |
| Moses Alan Charles | Director | filed 2021 - 2026 |
| Cohen Neil Harris | Director · interim CEO | filed 2021 - 2026 |
| Nicaise Claude | Director | filed 2021 - 2026 |
| Quigley Jill M. | Director | filed 2022 - 2026 |
| Maryles Joel Michael | Director | filed 2021 - 2022 |
| Pfost Dale R | Director · Chief Executive Officer | filed 2021 - 2022 |
| Squinto Stephen P | Director | filed 2021 - 2021 |
| Polovets Stanislav | Director | filed 2021 - 2021 |
| Hardy Reginald L | Director | filed 2020 - 2020 |
| Veru Dennison T | Director | filed 2020 - 2020 |
| Haluska Frank | Director · Chief Executive Officer | filed 2020 - 2020 |
| Makov Efrat | Director | filed 2020 - 2020 |
| Kohlberg Isaac T. | Director | filed 2020 - 2020 |
| Alon Ruth | Director | filed 2020 - 2020 |
| Gonen Ofer | Director | filed 2020 - 2020 |
| Howard Lawrence | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Fatal Sigal | Chief Financial Officer | filed 2021 - 2026 |
| Lawler John | Chief Development Officer | filed 2026 - 2026 |
| Frankel Matthew Bejosa | Chief Medical Officer | filed 2022 - 2022 |
| Marvin Donald | Executive VP, CFO & COO | filed 2021 - 2022 |
| Aharon Arnon | Chief Medical Officer | filed 2021 - 2021 |
| Fine Andrew | Chief Financial Officer | filed 2021 - 2021 |
| Dipalma Stephen J. | Chief Financial Officer | filed 2020 - 2020 |
| Burgin Jonathan | See Remarks | filed 2020 - 2020 |
| Daly Sean T | VP, Clinical Operations | filed 2020 - 2020 |
| Gilon Ohev-Zion Michal | VP, Research and Development | filed 2020 - 2020 |
| Knickerbocker Ron | See Remarks | filed 2020 - 2020 |
| Kerstein David | Chief Medical Officer | filed 2020 - 2020 |
| Roshan Salar | Head of Business Development | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.